Thyroid Cancer
From Emergent Biotechnologies to Clinical Practice Guidelines
Published on 19. April 2016
408 pages
978-1-040-16309-2 (ISBN)
Description
The current age of clinical medicine is witnessing biotechnological innovation at an unprecedented pace. As a result, the recently popularized clinical practice guidelines (CPG), as a tool to assist clinical decision-making, have been struggling to keep up. Thyroid Cancer: From Emergent Biotechnology to Clinical Practice Guidelines rides the wave o
More details
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
College/higher education
Professional and scholarly
File size
3,19 MB
ISBN-13
978-1-040-16309-2 (9781040163092)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Angelo Carpi | Jeffrey I. Mechanick
Thyroid Cancer
From Emergent Biotechnologies to Clinical Practice Guidelines
Book
10/2019
1st Edition
CRC Press
€95.20
Shipment within 15-20 days
Angelo Carpi | Jeffrey I. Mechanick
Thyroid Cancer
From Emergent Biotechnologies to Clinical Practice Guidelines
Book
05/2011
1st Edition
CRC Press
€142.60
Shipment within 15-20 days
Persons
Angelo Carpi, MD is a clinical researcher at the University Hospital of Pisa. He is also an associate professor of Internal Medicine at Pisa University.
Jeffrey I. Mechanick, MD, Mount Sinai School of Medicine, New York City, is a Clinical Professor within the Department of Medicine, Division of Endocrinology, Diabetes, and Bone Disease at the Mount Sinai School of Medicine.
Jeffrey I. Mechanick, MD, Mount Sinai School of Medicine, New York City, is a Clinical Professor within the Department of Medicine, Division of Endocrinology, Diabetes, and Bone Disease at the Mount Sinai School of Medicine.
Content
Principles of Translational Medicine and Applications to Thyroid Cancer Investigation. Systems Biology - An Overview. Genetic and Epigenetic Alterations in the MAP Kinase and PI3K/Akt Pathways in Thyroid Cancer. Genetic and Molecular Pathophysiology of Medullary Thyroid Carcinoma. Risk Stratification in Differentiated Thyroid Cancer. Clinical Practice Guidelines for Thyroid Cancer: Where Are We Now? Illustrative Case Studies of Thyroid-Carcinoma and the Emerging Role of Molecular Medicine. Advances In Thyroid Ultrasound For Detection And Follow-Up Of Thyroid Malignancies: Technical And Clinical Aspects. Multimodality Imaging and Aspiration Biopsy Guidance in the Perioperative Management of Thyroid Carcinoma. The Use of Diagnostic Radiotracers in Thyroid Cancer. PET-CT Scanning in the Management of Thyroid Cancer: Experience with a Cohort of 100 Patients. The Emerging Role of Percutaneous Needle Biopsy and Molecular Tumor Marker Analysis for the Preoperative Selection of Thyroid Nodules. Image-guided Mini-invasive Ablation of Thyroid Tumors and Distant Metastases. Thyroidectomy and Neck Exploration: New Surgical Approaches. Thyroid Surgery Performed under Local Anesthesia & Same-Day Surgery. The Use of Therapeutic Radiotracers in Thyroid Cancer. Role of Chemotherapy in Thyroid Cancer. Role of NF-KB In thyroid cancer. Biologically Targeted Therapies for Thyroid Cancers. Molecular Targeted Therapies of Medullary Thyroid Carcinoma.
